Bourin M - Search Results

1

Population pharmacokinetics of ceftazidime in burn patients.

Dailly E, Pannier M, Jolliet P, Bourin M. Dailly E, et al. Among authors: bourin m. Br J Clin Pharmacol. 2003 Dec;56(6):629-34. doi: 10.1046/j.1365-2125.2003.01915.x. Br J Clin Pharmacol. 2003. PMID: 14616422 Free PMC article.

2

Population pharmacokinetics of imipenem in burn patients.

Dailly E, Kergueris MF, Pannier M, Jolliet P, Bourin M. Dailly E, et al. Among authors: bourin m. Fundam Clin Pharmacol. 2003 Dec;17(6):645-50. doi: 10.1046/j.1472-8206.2003.00190.x. Fundam Clin Pharmacol. 2003. PMID: 15015709 Review.

3

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors.

Dailly E, Billaud E, Reliquet V, Breurec S, Perré P, Léautez S, Jolliet P, Bourin M, Raffi F. Dailly E, et al. Among authors: bourin m. Eur J Clin Pharmacol. 2004 Jul;60(5):343-8. doi: 10.1007/s00228-004-0769-5. Epub 2004 May 20. Eur J Clin Pharmacol. 2004. PMID: 15156302

4

Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance.

Dailly E, Urien S, Chanut E, Claudel B, Guerra N, Femandez C, Jolliet P, Bourin M. Dailly E, et al. Among authors: bourin m. Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):699-703. doi: 10.1016/s0278-5846(01)00320-7. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 12188102

5

Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice.

Dailly E, Hascoët M, Colombel MC, Jolliet P, Bourin M. Dailly E, et al. Among authors: bourin m. Hum Psychopharmacol. 2002 Jul;17(5):239-45. doi: 10.1002/hup.408. Hum Psychopharmacol. 2002. PMID: 12404681

6

An overview of the clinical pharmacokinetics of x-ray contrast media.

Bourin M, Jolliet P, Ballereau F. Bourin M, et al. Clin Pharmacokinet. 1997 Mar;32(3):180-93. doi: 10.2165/00003088-199732030-00002. Clin Pharmacokinet. 1997. PMID: 9084958 Review.

7

Dopamine, depression and antidepressants.

Dailly E, Chenu F, Renard CE, Bourin M. Dailly E, et al. Among authors: bourin m. Fundam Clin Pharmacol. 2004 Dec;18(6):601-7. doi: 10.1111/j.1472-8206.2004.00287.x. Fundam Clin Pharmacol. 2004. PMID: 15548230 Review.

8

A follow-up study of a population of schizophrenic patients treated with clozapine.

Bourin M, Guitton B, Dailly E, Hery P, Jolliet P. Bourin M, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Nov;25(8):1481-95. doi: 10.1016/s0278-5846(01)00213-5. Prog Neuropsychopharmacol Biol Psychiatry. 2001. PMID: 11642649

9

The use of benzodiazepines in the aged patient: clinical and pharmacological considerations.

Dailly E, Bourin M. Dailly E, et al. Among authors: bourin m. Pak J Pharm Sci. 2008 Apr;21(2):144-50. Pak J Pharm Sci. 2008. PMID: 18390445

10

Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test.

Renard CE, Dailly E, David DJ, Hascoet M, Bourin M. Renard CE, et al. Among authors: bourin m. Fundam Clin Pharmacol. 2003 Aug;17(4):449-55. doi: 10.1046/j.1472-8206.2003.00160.x. Fundam Clin Pharmacol. 2003. PMID: 12914547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters